Leidos continues to spur your returns

We first recommended Leidos to you as buy in our December 2017 issue at $62; your shares then rose to $125 in February 2020 before the coronavirus outbreak pulled down the market. Even so, Leidos is still up an impressive 50% since our initial 2017… Read More

Four ways spinoffs reward you

Spinoffs offer flexibility. Spinning off unwanted assets lets the parent company’s managers focus on that part of the business they want to retain. Usually they hold on to operations best suited to their talents.
Spun-off shares often slump when they begin trading. Many investors routinely dump stock they… Read More

See beyond this market

We think today’s bear market has done as much damage as it is likely to do. In fact, the market has now moved back up enough that investors worry about whether to buy now or to “wait for a dip” when “things settle down.”
My view… Read More

You’ll profit from Pfizer’s new focus

Under a new long-term strategy, Pfizer is concentrating on what it does best: developing new patented drugs that generate strong returns for its shareholders.
As part of that plan, the company is merging its over-the-counter and generic drugs businesses with those of other pharmaceutical firms to… Read More

Resist any urge to sell top picks

As I’ve said since mid-March, I suspect the bulk of the damage to the stock market may already be behind us. Obviously, I could be wrong. I’ll explain why and say more over the next few weeks in our newsletters and weekly Hotlines.
Meanwhile, I advise… Read More

Investors should gain from this breakup

In March 2019, activist investment firm Sachem Head Capital Management announced that it had acquired 8.9% of Eagle Materials. It now owns around 7% of the company.
Sachem originally pushed the company to sell its fracking sands business, which has struggled in recent years as oil… Read More

Fuel your returns with these spinoffs

New spinoff stocks often drift sideways for a few years until building a history of earnings and attracting analysts.
As a new spinoff from Danaher, Envista is still an attractive choice for aggressive investors. However, we’re less confident about Match Group’s short-term prospects even as parent… Read More

Investors expect low takeover offer

ED ROBIN GOURMET BURGERS INC. $5.18 is a sell. The company (Nasdaq symbol RRGB; Consumer sector; Shares outstanding: 12.9 million; Market cap: $66.8 million; No dividend paid; Takeover Target Rating: Highest; www.redrobin.com) is a casual dining chain with 556 Red Robin restaurant locations in the U.S. and Canada. About… Read More